Bleeding complications from the direct oral anticoagulants
Conclusions
Management of DOAC bleeding is variable. Clinical trial data regarding DOAC reversal is needed to facilitate optimization and standardization of bleeding treatment algorithms.
Source: BMC Hematology - Category: Hematology Source Type: research
More News: Academia | Bleeding | Clinical Trials | Gastroenterology | Hematology | Hospital Management | Pradaxa | Study